Susquehanna Fundamental Investments, LLC Y M Abs Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

  • $4.33 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$4.88 - $7.42 $70,652 - $107,426
-14,478 Reduced 35.35%
26,482 $181 Million
Q1 2023

May 16, 2023
SELL
$2.83 - $5.11 $4,861 - $8,778
-1,718 Reduced 4.03%
40,960 $205,000
Q4 2022

Feb 14, 2023
BUY
$3.0 - $15.17 $128,034 - $647,425
42,678 New
42,678 $208,000

Others Institutions Holding YMAB

# of Institutions
106
Shares Held
24.5M
Call Options Held
40.3K
Put Options Held
400
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $356M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email